BioSpace News Archive

Business

Cronos Group and Ginkgo Bioworks Announce a Landmark Partnership to Produce Cultured Cannabinoids

Leading Companies from Emerging Industries Join Forces to Efficiently Produce High-Purity Cannabinoids at Scale

September 4, 2018
·
9 min read
Deals

Correvio Highlights Completion of SteadyMed Acquisition by United Therapeutics

Correvio Pharma Corp. today highlighted that United Therapeutics (NASDAQ: UTHR) has completed its acquisition of SteadyMed Ltd., Correvio’s partner and the licensor of Trevyent®.

September 4, 2018
·
7 min read
FDA

CytoSorbents REFRESH 2-AKI Protocol Amendment Approved by FDA

CytoSorbents Corporation announced that the REFRESH 2-AKI trial protocol amendment that was discussed in the August 2, 2018 earnings press release, has now been approved by the U.S. Food and Drug Administration (FDA).

September 4, 2018
·
4 min read
Lone Star Bio

HeartSciences Named Among ‘50 Smartest Companies of the Year 2018’ by The Silicon Review Magazine

Silicon Review, a leading Business and Technology magazine has named HeartSciences, as one of the 50 Smartest Companies of the Year 2018.

September 4, 2018
·
2 min read
Business

Aura Biosciences Boosts Finance Team with Two Key Appointments, Preparing to Move Into Late-Stage Clinical Development in Ocular Melanoma

Aura Biosciences today announced that Julie Feder has joined the company’s leadership team as Chief Financial Officer.

September 4, 2018
·
3 min read
Business

Seres Therapeutics Strengthens Board of Directors with Appointment of Meryl Zausner, Experienced Biopharmaceutical Financial Leader

Seres Therapeutics, Inc. today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial and operational leadership experience in the pharmaceutical industry.

September 4, 2018
·
4 min read
Deals

Transcat Acquires Angel’s Instrumentation Inc.

Acquisition expands geographic presence to Virginia and broadens industrial on-site calibration capabilities

September 4, 2018
·
4 min read
Drug Development

Top Line Results of the Namodenoson Phase II Advanced Liver Cancer Trial Expected by End of Year

Namodenoson seeks to address a major unmet need for Child Pugh B patients with advanced liver cancer

September 4, 2018
·
7 min read
Genetown

Acceleron to Participate in Three Upcoming September and October 2018 Healthcare Investor Conferences

Acceleron Pharma Inc. today announced that senior management will participate in three upcoming healthcare investor conferences.

September 4, 2018
·
2 min read
Deals

Penumbra, Inc. Announces Acquisition of Controlling Interest in MVI Health

Penumbra increased its ownership to 90 percent of the equity of MVI Health for $20 million in upfront cash consideration.

September 4, 2018
·
3 min read